Fox Chase Cancer Center’s Dr. Alexander Kutikov Co-Edits New Issue of Urologic Clinics of North America

Kutikov
Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center

PHILADELPHIA (May 5, 2025) — Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, recently co-edited and contributed to a new edition of Urologic Clinics of North America.

The May issue of the journal, which provides important clinical updates in the field of urology, focuses on the comprehensive medical and surgical management of adrenal pathology and features review articles written by leading experts in the field.

“This edition is an update for the field that includes both urology and all the other specialties that take care of adrenal masses. It gives a comprehensive overview of where things stand, from metabolic work up, to medical management, and of course, surgical approaches in that space,” said Kutikov, who is also a member of the executive management team of the Fox Chase - Temple Urologic Institute

Adrenal masses are abnormal growths found on the adrenal glands — located just above the kidneys — that can be benign or cancerous and can also secrete an excessive amount of hormones into the bloodstream. 

Kutikov, who specializes in surgical treatment of adrenal tumors, co-edited the edition with Benjamin Ristau, MD, MHA, a urologic oncologist at UConn Health and former urologic oncology fellow at Fox Chase, who Kutikov helped train. In addition to editing the issue, Kutikov and Ristau contributed articles to the publication that discuss adrenal surgery and adrenal hormonal disorders.

The issue also discusses adrenal gland physiology and pathologic conditions and offers insight into management of adrenal disorders from practicing urologists. It also provides expert guidance on robotic and laparoscopic surgery for adrenal patients as well as expertise on metabolic treatments and diagnostic workups.

“We put together a panel of international experts in this very small but very specialized field,” said Kutikov. “Adrenal patients are not common, but we see a lot of them at Fox Chase, so we’re very proud of this work. It serves as an important contribution to this important and ever-changing field.” 

In addition to contributing to the issue, Kutikov and Ristau also recently helped develop a website, a resource from the Global Society of Rare Genitourinary Tumors. The website is designed to serve as a point-of-care information resource for physicians who encounter patients with adrenal masses. The goal of the website, adrenalmass.org, is to provide physicians with high-quality information and also educate patients about these complex conditions. The website offers management guidance as well as clinical tools and practice updates.

“We’ve had the privilege of contributing to the literature in many important areas of urologic oncology, but being invited to curate this issue on adrenal disorders was a distinct honor,” said Kutikov. “Our hope is that this publication — together with the adrenalmass.org website — serves as a trusted, practical resource for physicians navigating the challenges of adrenal pathology and also helps educate patients facing these complex diagnoses,” said Kutikov.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427